Serametrix Corporation

Caprion Biosciences expands its global biomarker and immune monitoring franchise by acquiring Serametrix Corporation

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Caprion BioSciences, regarding the acquisition of Serametrix Corporation. Caprion Biosciences announced that the company acquired Serametrix Corporation, a specialised provider of immune monitoring services headquartered in Carlsbad, California. Caprion plans to… read more

Subscribe to our email alerts

Email updates